Find your next paid study

Wake Forest University Health SciencesNCT06567704

Actual pay is set by the research site.

MRI Technology for Greater Efficiency and Improved Value

The goal of this clinical trial is to find out if new Magnetic Resonance Imaging (MRI) computer software will: * help make scans and exams faster * reduce art…

Brain MRI

University of Wisconsin, MadisonNCT07167953

Actual pay is set by the research site.

IMPACT Trial: Intervention to iMProve AdherenCe Equitably

To determine the efficacy of a multicomponent adherence intervention among participants with early-stage breast cancer on endocrine therapy and at least one or…

Breast Cancer

Columbia UniversityNCT05496829

Actual pay is set by the research site.

Phase 2

A Two Part, Randomized Study of MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers

DL-VSU-201 is a randomized, double-blind, placebo-controlled study in subjects with a non-infected venous stasis ulcer (VSU) that has failed to demonstrate imp…

Venous Stasis UlcerVenous Leg Ulcer

Merakris TherapeuticsNCT04647240

~$75 – $2,800

Actual pay is set by the research site.

Phase 2

A Phase 2B Study of Selinexor (KPT-330), in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma Relapsing on Current Therapy

This is a prospective, 2-arm (with an additional exploratory arm), open-label, multicenter study looking at the response rate of patients receiving selinexor (…

Multiple Myeloma

Hackensack Meridian HealthNCT04661137

~$75 – $3,000

Actual pay is set by the research site.

Phase 1

A Phase 1/2 Open-Label Rolling-Arm Umbrella Platform Study of Investigational Agents in Combination With Enfortumab Vedotin Plus Pembrolizumab as First-Line Treatment in Participants With Locally Advanced or Metastatic Urothelial Carcinoma: KEYMAKER-U04-Substudy 04D

Researchers are looking for new ways to treat people with urothelial cancer (UC) that is locally advanced or metastatic. The standard treatment for locally adv…

Bladder Cancer

Merck Sharp & Dohme LLCNCT07232602

~$150 – $4,200

Actual pay is set by the research site.

Phase 4

Subcutaneous Versus Intravenous Immune Checkpoint Inhibitors, Treatment Burden, and Care Delivery for Patients With Renal Cell Carcinoma

The purpose of this study is to see if people prefer immunotherapy treatment for kidney cancer delivered intravenously or subcutaneously and if it is practical…

Renal Cell CarcinomaKidney Cancer

Memorial Sloan Kettering Cancer CenterNCT07872553

~$25 – $1,000

Actual pay is set by the research site.

Phase 3

A Prospective, Multicenter, Open-label, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Prophylactic VGA039 in Adolescent and Adult Patients With Von Willebrand Disease (VIVID-6)

This is a phase 3 study that will evaluate subcutaneous (SC) VGA039 in patients with von Willebrand Disease (VWD)

Von Willebrand Disease (VWD)

Vega Therapeutics, IncNCT07115004

~$50 – $2,100

Actual pay is set by the research site.

Phase 1

An Open-label, Single-sequence, Crossover Study Investigating the Influence of UBT251 on Pharmacokinetics of Index Substrates for Cytochrome P450 Enzymes in Participants With Overweight or Obesity

The purpose of this clinical study is to find out if UBT251 is safe and effective to be taken together with medicines, like midazolam, caffeine and warfarin in…

ObesityOverweight

Novo Nordisk A/SNCT07710768

~$500 – $11,250

Actual pay is set by the research site.

Short Bowel SyndromeMalabsorption

A 90 Day, Phase 3, Open Labeled Exploratory Study of RELiZORB to Evaluate Safety, Tolerability, and Nutrient Absorption in Children With Short Bowel Syndrome Who Are Dependent on Parenteral Nutrition

Children with inadequate intestinal absorption due to loss of large amounts of small bowel require intravenous nutrition (feeding through the vein) to sustain …

Boston Children's HospitalNCT03530852

Actual pay is set by the research site.

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

This study will assess whether a quantitative, HER2 assay can accurately and reliably discriminate between responders and non-responders among patients with HE…

HER2-positive Metastatic Breast Cancer

Abramson Cancer Center at Penn MedicineNCT06551116

Actual pay is set by the research site.

E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control

This study aims to compare a multidisciplinary clinical hypertension and social needs intervention to enhanced standard of care for hypertension management in …

Hypertension